Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0569
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-07-26T06:08:51.196946Z
status: published
lens: g_space
sector: health
headline: Epigenomics-Guided Multi-Omics Integration Uncovers a Lipid-Metabolic Signature with Translational Utility in Bladder Cancer
dek: Background: Bladder cancer (BLCA) exhibits marked heterogeneity, and current classifiers provide limited guidance for prognosis or treatment. Because epigenetic reprogramming and metabolic rewiring jointly shape BLCA biology, we sought to identify epigenomically informed biomarkers with functional relevance. Methods: Epigenome (genome-wide promoter DNA methylation) and matched transcriptome (RNA sequencing) profiles from tumor and adjacent normal samples were integrated to identify genes with concordant differen…
gain_title: A survival-oriented machine learning framework distilled epigenomic and transcriptomic data into a 25-gene lipid-metabolic signature that stratified bladder cancer patients by risk across multiple cohorts and identified FASN and SCD as inhibitable drivers of proliferation and migration in cell models.
problem_title: (none)
trace_subject: (none)
gain_reading: A survival-oriented machine learning framework distilled epigenomic and transcriptomic data into a 25-gene lipid-metabolic signature that stratified bladder cancer patients by risk across multiple cohorts and identified FASN and SCD as inhibitable drivers of proliferation and migration in cell models.
gain_evidence: stratified patients into high- and low-risk groups across the discovery and 4 validation datasets. | their inhibition reduced BLCA cell proliferation and migration, supporting pathway-level functional relevance.
problem_reading: (none)
problem_evidence: (none)
quick_read: On July 24, 2026, a peer-reviewed study reported integration of promoter methylation and RNA sequencing data from bladder cancer tumors and adjacent normal tissue to identify epigenetically regulated genes, then used a survival-oriented machine learning framework to distill a 25-gene signature enriched for cell cycle and lipid metabolism. The signature stratified patients into high- and low-risk groups in the discovery set and 4 independent validation cohorts, and network analysis highlighted fatty acid synthase and stearoyl-coenzyme A desaturase whose inhibition reduced proliferation and migration in cell line assays.

The work matters because current bladder cancer classifiers provide limited prognostic guidance, and a stage-independent, experimentally vetted lipid-centric signature could inform risk stratification and nominate metabolic therapeutic targets. What remains uncertain is clinical translation, as immune phenotypes and drug sensitivities were computationally inferred and functional validation was limited to in vitro colony formation and migration assays without prospective patient testing.
limitation: 
tag: Evidence-backed gain
key_points: Integrated genome-wide promoter DNA methylation and matched RNA sequencing from tumor and adjacent normal samples to find concordant methylation-expression changes. | Distilled candidates into a 25-gene signature enriched for cell cycle regulation and lipid metabolism using a survival-oriented machine learning framework. | Validated prognostic performance in 4 independent BLCA cohorts with value independent of age, pathological stage, and common genomic alterations. | Network analysis identified fatty acid synthase and stearoyl-coenzyme A desaturase as central nodes; pharmacological inhibition reduced proliferation and migration in BLCA cell line models.
rundown: Researchers integrated epigenome (genome-wide promoter DNA methylation) and matched transcriptome (RNA sequencing) from bladder tumor and adjacent normal samples to identify genes with concordant differential patterns, then applied a survival-oriented machine learning framework to derive a 25-gene signature.

The signature stratified patients into high- and low-risk groups across discovery and 4 validation datasets, remained independent of age, stage, and common genomic alterations, and was characterized by computational immune cell inference and in silico drug sensitivity, with low-risk tumors showing immune-inflamed phenotypes and high-risk showing lower IC50 values for several drugs.
sources:
- peer_reviewed | Computational and Structural Biotechnology Journal | https://doi.org/10.34133/csbj.0139 | 2026-07-24
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

f609e66d0ef10095d6667f8e610a72812e46092210ad339bcf061571fb565751

previous

0000000000000000000000000000000000000000000000000000000000000000